$BMRN
BIOMARIN PHARMACEUTICAL INC

2014 Q4 Form 10-Q Financial Statement

#000119312514384895 Filed on October 28, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $230.1M $176.5M $136.9M
YoY Change 56.64% 28.99% 6.84%
Cost Of Revenue $38.30M $29.92M $28.05M
YoY Change 55.69% 6.65% 13.95%
Gross Profit $191.7M $146.6M $108.8M
YoY Change 56.75% 34.74% 5.14%
Gross Profit Margin 83.31% 83.05% 79.5%
Selling, General & Admin $103.1M $74.60M $61.84M
YoY Change 45.21% 20.64% 33.46%
% of Gross Profit 53.78% 50.88% 56.83%
Research & Development $142.1M $125.7M $88.06M
YoY Change 46.04% 42.72% 33.01%
% of Gross Profit 74.13% 85.72% 80.93%
Depreciation & Amortization $6.000M $11.20M $9.200M
YoY Change -500.0% 21.74% 3.37%
% of Gross Profit 3.13% 7.64% 8.45%
Operating Expenses $253.5M $200.3M $149.9M
YoY Change 40.52% 33.61% 33.19%
Operating Profit -$61.80M $11.20M -$50.72M
YoY Change 6.37% -122.09% 383.5%
Interest Expense -$4.300M $9.118M $526.0K
YoY Change -458.33% 1633.46% -71.37%
% of Operating Profit 81.39%
Other Income/Expense, Net $300.0K -$100.0K $200.0K
YoY Change -50.0% -150.0% 100.0%
Pretax Income -$65.70M $3.221M -$52.32M
YoY Change 10.61% -106.16% 344.83%
Income Tax $4.100M -$4.224M $704.0K
% Of Pretax Income -131.14%
Net Earnings -$69.80M $7.445M -$53.02M
YoY Change 12.58% -114.04% 889.73%
Net Earnings / Revenue -30.33% 4.22% -38.74%
Basic Earnings Per Share $0.05 -$0.38
Diluted Earnings Per Share -$471.0K $0.05 -$0.38
COMMON SHARES
Basic Shares Outstanding 147.5M shares 147.0M 140.8M shares
Diluted Shares Outstanding 159.3M 140.8M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $945.2M $666.4M $379.7M
YoY Change 20.45% 75.51% -10.97%
Cash & Equivalents $875.5M $398.0M $181.6M
Short-Term Investments $69.70M $268.4M $198.1M
Other Short-Term Assets $108.5M $56.46M $28.16M
YoY Change 160.21% 100.48% -48.63%
Inventory $199.5M $204.4M $148.7M
Prepaid Expenses $35.39M
Receivables $144.5M $121.4M $124.7M
Other Receivables $9.700M $0.00 $0.00
Total Short-Term Assets $1.398B $1.078B $713.5M
YoY Change 22.88% 51.07% -0.82%
LONG-TERM ASSETS
Property, Plant & Equipment $523.5M $486.7M $285.7M
YoY Change 63.95% 70.39% 4.36%
Goodwill $54.26M $54.26M $54.26M
YoY Change 0.0% 0.0% 5.27%
Intangibles $156.6M $159.9M $165.8M
YoY Change -4.03% -3.52% 0.1%
Long-Term Investments $97.90M $449.1M $148.6M
YoY Change -63.54% 202.22% 38.1%
Other Assets $54.56M $61.53M $14.01M
YoY Change -65.07% 339.2% -29.02%
Total Long-Term Assets $1.078B $1.363B $907.1M
YoY Change -2.61% 50.22% 6.96%
TOTAL ASSETS
Total Short-Term Assets $1.398B $1.078B $713.5M
Total Long-Term Assets $1.078B $1.363B $907.1M
Total Assets $2.475B $2.440B $1.621B
YoY Change 10.31% 50.59% 3.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.78M $37.69M $15.63M
YoY Change -11.15% 141.1% 36.42%
Accrued Expenses $98.49M $78.06M $58.67M
YoY Change 68.62% 33.06% 61.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $235.7M $206.6M $167.6M
YoY Change 28.63% 23.22% 24.24%
LONG-TERM LIABILITIES
Long-Term Debt $642.9M $656.9M $78.30M
YoY Change -1.94% 738.95% -75.9%
Other Long-Term Liabilities $30.08M $26.26M $34.41M
YoY Change -9.93% -23.69% -62.76%
Total Long-Term Liabilities $30.08M $26.26M $34.41M
YoY Change -9.93% -23.69% -62.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $235.7M $206.6M $167.6M
Total Long-Term Liabilities $30.08M $26.26M $34.41M
Total Liabilities $947.5M $932.0M $344.0M
YoY Change 4.92% 170.89% -37.69%
SHAREHOLDERS EQUITY
Retained Earnings -$849.8M -$780.0M -$653.8M
YoY Change 18.72% 19.3% 34.41%
Common Stock $2.360B $2.279B $1.926B
YoY Change 14.6% 18.31% 27.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.528B $1.508B $1.276B
YoY Change
Total Liabilities & Shareholders Equity $2.475B $2.440B $1.621B
YoY Change 10.31% 50.59% 3.39%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$69.80M $7.445M -$53.02M
YoY Change 12.58% -114.04% 889.73%
Depreciation, Depletion And Amortization $6.000M $11.20M $9.200M
YoY Change -500.0% 21.74% 3.37%
Cash From Operating Activities -$25.40M -$8.100M -$9.500M
YoY Change 182.22% -14.74% -166.9%
INVESTING ACTIVITIES
Capital Expenditures -$27.80M -$24.60M -$13.20M
YoY Change -6.71% 86.36% -12.0%
Acquisitions
YoY Change
Other Investing Activities $490.5M -$162.3M $16.50M
YoY Change -277.2% -1083.64% -379.66%
Cash From Investing Activities $462.7M -$186.9M $3.300M
YoY Change -250.96% -5763.64% -115.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 43.00M 8.900M 12.30M
YoY Change -93.9% -27.64% 19.42%
NET CHANGE
Cash From Operating Activities -25.40M -8.100M -9.500M
Cash From Investing Activities 462.7M -186.9M 3.300M
Cash From Financing Activities 43.00M 8.900M 12.30M
Net Change In Cash 480.3M -186.1M 6.100M
YoY Change 23.31% -3150.82% 74.29%
FREE CASH FLOW
Cash From Operating Activities -$25.40M -$8.100M -$9.500M
Capital Expenditures -$27.80M -$24.60M -$13.20M
Free Cash Flow $2.400M $16.50M $3.700M
YoY Change -88.46% 345.95% -87.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
78.45
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2441000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
3801000
CY2013Q2 bmrn Accumulated Other Comprehensive Income Loss Tax
AccumulatedOtherComprehensiveIncomeLossTax
-1360000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9941000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
15491000
CY2014Q2 bmrn Accumulated Other Comprehensive Income Loss Tax
AccumulatedOtherComprehensiveIncomeLossTax
-5550000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11473000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
16981000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181565000
CY2013Q3 bmrn Accumulated Other Comprehensive Income Loss Tax
AccumulatedOtherComprehensiveIncomeLossTax
-5508000
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
147433951 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
147433951 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
94.15
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
215892000
CY2014Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
11840000
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
206550000
CY2014Q3 us-gaap Deferred Compensation Cash Based Arrangements Liability Current
DeferredCompensationCashBasedArrangementsLiabilityCurrent
1372000
CY2014Q3 us-gaap Other Commitment
OtherCommitment
46000000
CY2014Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
975849000
CY2014Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
66916000
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
40918000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
398005000
CY2014Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12476000
CY2014Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
656884000
CY2014Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
472000
CY2014Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7572000
CY2014Q3 us-gaap Goodwill
Goodwill
54258000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
486741000
CY2014Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1159641000
CY2014Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
716696000
CY2014Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
716696000
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
195000
CY2014Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
13711000
CY2014Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
5026000
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
29956000
CY2014Q3 us-gaap Liabilities
Liabilities
931991000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
148000
CY2014Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
3167000
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
19189000
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
37689000
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-779973000
CY2014Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4705000
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2278761000
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78063000
CY2014Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
206550000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
1508442000
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26260000
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5654000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2440433000
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38266000
CY2014Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
74430000
CY2014Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
198215000
CY2014Q3 us-gaap Marketable Securities Equity Securities
MarketableSecuritiesEquitySecurities
26600000
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
150991000
CY2014Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1021000
CY2014Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
12613000
CY2014Q3 us-gaap Escrow Deposit
EscrowDeposit
0
CY2014Q3 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
10600000
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
64021000
CY2014Q3 us-gaap Other Assets
OtherAssets
9887000
CY2014Q3 us-gaap Property Plant And Equipment Fair Value Disclosure
PropertyPlantAndEquipmentFairValueDisclosure
19971000
CY2014Q3 us-gaap Assets
Assets
2440433000
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
702633000
CY2014Q3 bmrn Other Assets Current Fair Value Disclosure
OtherAssetsCurrentFairValueDisclosure
8734000
CY2014Q3 us-gaap Long Term Investments
LongTermInvestments
448328000
CY2014Q3 bmrn Accumulated Other Comprehensive Income Loss Tax
AccumulatedOtherComprehensiveIncomeLossTax
-10767000
CY2014Q3 bmrn Contingent And Deferred Acquisition Payments
ContingentAndDeferredAcquisitionPayments
42297000
CY2014Q3 bmrn Other Liabilities Current Fair Value Disclosure
OtherLiabilitiesCurrentFairValueDisclosure
1495000
CY2014Q3 bmrn Business Combination Contingent Consideration At Fair Value Current
BusinessCombinationContingentConsiderationAtFairValueCurrent
0
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
143463668 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
143463668 shares
CY2014Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
448328000
CY2014Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
398005000
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
29149000
CY2014Q3 us-gaap Inventory Net
InventoryNet
204444000
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19946000
CY2014Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
815000
CY2014Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
36206000
CY2014Q3 us-gaap Short Term Investments
ShortTermInvestments
268368000
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
121395000
CY2014Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
717245000
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
159949000
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
56458000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
61532000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
1077819000
CY2014Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
268368000
CY2014Q3 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
9683000
CY2014Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
123785000
CY2014Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
120477000
CY2014Q3 us-gaap Investments
Investments
26556000
CY2014Q3 bmrn Other Liabilities Noncurrent Fair Value Disclosure
OtherLiabilitiesNoncurrentFairValueDisclosure
65421000
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
147465546 shares
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-202000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-222000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180527000
CY2012Q4 bmrn Accumulated Other Comprehensive Income Loss Tax
AccumulatedOtherComprehensiveIncomeLossTax
20000
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
185043000
CY2013Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
10487000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
183271000
CY2013Q4 us-gaap Deferred Compensation Cash Based Arrangements Liability Current
DeferredCompensationCashBasedArrangementsLiabilityCurrent
1363000
CY2013Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
1012335000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
144000
CY2013Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4122000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5018000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
36894000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-715801000
CY2013Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3603000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2059101000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
58408000
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
183271000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1341041000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33392000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4875000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2244060000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
29525000
CY2013Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
10429000
CY2013Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
6005000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
7757000
CY2013Q4 us-gaap Liabilities
Liabilities
903019000
CY2013Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
66147000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33496000
CY2013Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
655566000
CY2013Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
432000
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5829000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
529000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
568781000
CY2013Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
7196000
CY2013Q4 us-gaap Goodwill
Goodwill
54258000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
319316000
CY2013Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1075159000
CY2013Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
483642000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
483642000
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
74430000
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
192672000
CY2013Q4 us-gaap Marketable Securities Equity Securities
MarketableSecuritiesEquitySecurities
13000000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
145234000
CY2013Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
423000
CY2013Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
15374000
CY2013Q4 us-gaap Escrow Deposit
EscrowDeposit
116500000
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
58879000
CY2013Q4 us-gaap Other Assets
OtherAssets
4101000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
504359000
CY2013Q4 us-gaap Long Term Investments
LongTermInvestments
267700000
CY2013Q4 us-gaap Assets
Assets
2244060000
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136102000 shares
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
12152000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
267700000
CY2013Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
568781000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
30561000
CY2013Q4 us-gaap Inventory Net
InventoryNet
162605000
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15309000
CY2013Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
816000
CY2013Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
16871000
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
215942000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
117822000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
483633000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
163147000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
41707000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
156171000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
1137418000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
215942000
CY2013Q4 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
7421000
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
118242000
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
88417000
CY2013Q4 us-gaap Investments
Investments
13000000
CY2013Q4 bmrn Other Liabilities Noncurrent Fair Value Disclosure
OtherLiabilitiesNoncurrentFairValueDisclosure
50716000
CY2013Q4 bmrn Accumulated Other Comprehensive Income Loss Tax
AccumulatedOtherComprehensiveIncomeLossTax
-2739000
CY2013Q4 bmrn Contingent And Deferred Acquisition Payments
ContingentAndDeferredAcquisitionPayments
30790000
CY2013Q4 bmrn Other Liabilities Current Fair Value Disclosure
OtherLiabilitiesCurrentFairValueDisclosure
15431000
CY2013Q4 bmrn Business Combination Contingent Consideration At Fair Value Current
BusinessCombinationContingentConsiderationAtFairValueCurrent
11882000
CY2013Q4 bmrn Other Assets Current Fair Value Disclosure
OtherAssetsCurrentFairValueDisclosure
5865000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-48338000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136102000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18923000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-114363000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1692000
us-gaap Contracts Revenue
ContractsRevenue
2778000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-4149000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
394074000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
179192000
us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
0
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-1918000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11675000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
1893000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
307000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
335000
us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
0
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
485000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
344000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
17228000
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
17203000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19989000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
269816000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9875000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax
349000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
11007000
us-gaap Operating Income Loss
OperatingIncomeLoss
-103697000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102688000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
17228000
us-gaap Income Taxes Paid
IncomeTaxesPaid
13165000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-117128000
us-gaap Royalty Revenue
RoyaltyRevenue
4760000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-1844000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1893000
us-gaap Interest Paid Net
InterestPaidNet
3238000
us-gaap Revenues
Revenues
401612000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35440000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-114363000
us-gaap Net Income Loss
NetIncomeLoss
-114363000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1942000
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15679000
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6141000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-2886000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11007000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1225000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1776000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-711000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41698000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
2618000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19212000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-6221000
us-gaap Interest Expense
InterestExpense
2854000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
257468000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
163547000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
9816000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
335000
us-gaap Other Noncash Expense
OtherNoncashExpense
939000
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
0
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1038000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
4200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2765000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-968000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-619000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
693000
us-gaap Cost Of Revenue
CostOfRevenue
71121000
us-gaap Depreciation
Depreciation
27300000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
37528000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
41743000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-6221000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-528000
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
12152000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
7633000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
60229000
us-gaap Costs And Expenses
CostsAndExpenses
505309000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-5528000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
1042000
us-gaap Paid In Kind Interest
PaidInKindInterest
352000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
232625000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11362000
us-gaap Share Based Compensation
ShareBasedCompensation
42638000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5368000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0
bmrn Stockbased Compensation Capitalized
StockbasedCompensationCapitalized
4219000
bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
13173000
bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
8221000
bmrn Supplemental Accounts Payable And Accrued Liabilities
SupplementalAccountsPayableAndAccruedLiabilities
-7491000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1177376 shares
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
BIOMARIN PHARMACEUTICAL INC
dei Trading Symbol
TradingSymbol
BMRN
us-gaap Asset Retirement Obligation Period Increase Decrease
AssetRetirementObligationPeriodIncreaseDecrease
-1041000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>(4) RECENT ACCOUNTING PRONOUNCEMENTS</b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> Except as described below, there have been no new accounting pronouncements or changes to accounting pronouncements during the nine months ended September&#xA0;30, 2014, as compared to the recent accounting pronouncements described in the Company&#x2019;s Annual Report on Form 10-K for the year-ended December&#xA0;31, 2013, that are of significance or potential significance to the Company.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2014-09 (ASU 2014-09), <i>Revenue from Contracts with Customers.</i> ASU 2014-09 will supersede the revenue recognition requirements in <i>Revenue Recognition (Topic 605)</i> and requires entities to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December&#xA0;15, 2016, including interim periods within that reporting period, which for the Company is January&#xA0;1, 2017. Early adoption is not permitted.&#xA0;The Company is currently evaluating the potential impact the adoption of ASU 2014-09 will have on its consolidated financial statements.</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.90
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>(1) NATURE OF OPERATIONS AND BUSINESS RISKS</b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> BioMarin Pharmaceutical Inc. (the Company or BioMarin), a Delaware corporation, develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. BioMarin selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market or offer a significant benefit over existing products. The Company&#x2019;s product portfolio is comprised of five approved products and multiple investigational product candidates. The Company&#x2019;s approved products are VIMIZIM (elosulfase alpha), Naglazyme (galsulfase), Kuvan (sapropterin dihydrochloride), Aldurazyme (laronidase) and Firdapse (amifampridine phosphate).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> Through September&#xA0;30, 2014, the Company had accumulated losses of approximately $780.0 million. The Company expects to continue to finance future cash needs that exceed its operating activities primarily through its current cash, cash equivalents, short-term and long-term investments, and to the extent necessary, through proceeds from equity or debt financings, loans and collaborative agreements with corporate partners. If the Company elects to increase its spending on development programs significantly above current long-term plans or enters into potential licenses and other acquisitions of complementary technologies, products or companies, the Company may need additional capital.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The Company is subject to a number of risks, including: the financial performance of VIMIZIM, Naglazyme, Kuvan, Aldurazyme and Firdapse; the potential need for additional financings; the Company&#x2019;s ability to successfully commercialize its approved product candidates, if approved; the uncertainty of the Company&#x2019;s research and development efforts resulting in future successful commercial products; the Company&#x2019;s ability to successfully obtain regulatory approval for new products; significant competition from larger organizations; reliance on the proprietary technology of others; dependence on key personnel; uncertain patent protection; dependence on corporate partners and collaborators; and possible restrictions on reimbursement from governmental agencies and healthcare organizations, as well as other changes in the health care industry.</p> </div>
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-46762000
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>(2) BASIS OF PRESENTATION</b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The accompanying Condensed Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the SEC for Quarterly Reports on Form 10-Q and do not include all of the information and note disclosures required by U.S. generally accepted accounting principles (U.S. GAAP) for complete financial statements. The Condensed Consolidated Financial Statements should therefore be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended December&#xA0;31, 2013 included in the Company&#x2019;s Annual Report on Form 10-K.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The accompanying Condensed Consolidated Financial Statements have been prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying disclosures. Although these estimates are based on management&#x2019;s best knowledge of current events and actions that the Company may undertake in the future, actual results may be different from those estimates. The Condensed Consolidated Financial Statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of results for these interim periods. The results of operations for the three and nine months ended September&#xA0;30, 2014 are not necessarily indicative of the results that may be expected for the fiscal year ending December&#xA0;31, 2014.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The Company has evaluated events and transactions subsequent to the balance sheet date. Based on this evaluation, the Company is not aware of any events or transactions that occurred subsequent to the balance sheet date but prior to filing this Quarterly Report on Form 10-Q that would require recognition or disclosure in the Condensed Consolidated Financial Statements.</p> </div>
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145724000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
dei Entity Central Index Key
EntityCentralIndexKey
0001048477
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24559000 shares
us-gaap Income Taxes Paid
IncomeTaxesPaid
22378000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-59131000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-36000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6718000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
13656000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14171000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b><i>Reclassifications</i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> Certain items in the Company&#x2019;s prior year Condensed Consolidated Financial Statements have been reclassified to conform to the current presentation.</p> </div>
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145724000 shares
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
674000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-64172000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2354000
us-gaap Contracts Revenue
ContractsRevenue
1274000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-5748000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
510664000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
448938000
us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
4691000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
205000
us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
116500000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1100000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-68000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
8579000
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
22199000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
19200000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
41839000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
16482000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax
-373000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5474000
us-gaap Operating Income Loss
OperatingIncomeLoss
-34135000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50001000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
8579000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2000000
us-gaap Royalty Revenue
RoyaltyRevenue
8248000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
205000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-3105000
us-gaap Other Noncash Expense
OtherNoncashExpense
360000
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
67500000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
11202000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
9395000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-36000
us-gaap Interest Paid Net
InterestPaidNet
4759000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
11300000
us-gaap Revenues
Revenues
520186000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89628000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-64172000
us-gaap Net Income Loss
NetIncomeLoss
-64172000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4293000
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3573000
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
8893000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7246000
us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
19971000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
14691000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5474000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
8733000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
9783000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1102000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
67500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53559000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
126000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12373000
us-gaap Interest Expense
InterestExpense
27445000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
319554000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
202524000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
86000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-170776000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
5700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5041000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
1035000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
662000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-4923000
us-gaap Cost Of Revenue
CostOfRevenue
83946000
us-gaap Depreciation
Depreciation
31300000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
39921000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
142676000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-3105000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
117463000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-16000
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
674000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-266690000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
37635000
us-gaap Costs And Expenses
CostsAndExpenses
554321000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-8028000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-5296000
us-gaap Paid In Kind Interest
PaidInKindInterest
20305000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
207476000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
31493000
us-gaap Share Based Compensation
ShareBasedCompensation
55251000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-116000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0
bmrn Stockbased Compensation Capitalized
StockbasedCompensationCapitalized
5663000
bmrn Number Of Purchased Buildings
NumberOfPurchasedBuildings
2 Building
bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
15797000
bmrn Number Of Products Approved
NumberOfProductsApproved
5 Product
bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
7989000
bmrn Number Of Customers Accounted For Largest Balance In Account Receivable
NumberOfCustomersAccountedForLargestBalanceInAccountReceivable
2 Customer
bmrn Contingent Payments Upon Achievement Of Certain Regulatory And Licensing Milestones
ContingentPaymentsUponAchievementOfCertainRegulatoryAndLicensingMilestones
561900000
bmrn Supplemental Accounts Payable And Accrued Liabilities
SupplementalAccountsPayableAndAccruedLiabilities
-2762000
CY2014Q3 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
67500000
CY2013 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
10100000
CY2013 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-2400000
CY2013 bmrn Number Of Customers Accounted For Largest Balance In Account Receivable
NumberOfCustomersAccountedForLargestBalanceInAccountReceivable
2 Customer
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1500000 shares
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
117500000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2013Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140796000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2013Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18986000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140796000 shares
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-53020000
CY2013Q3 us-gaap Contracts Revenue
ContractsRevenue
1754000
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
134330000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-3177000
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9032000
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
1693000
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61841000
CY2013Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-5296000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9368000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-2029000
CY2013Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
239000
CY2013Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
14664000
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-147000
CY2013Q3 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16205000
CY2013Q3 us-gaap Interest Expense
InterestExpense
526000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
88064000
CY2013Q3 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
13180000
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax
36000
CY2013Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
9368000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-50724000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43988000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
14664000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-52316000
CY2013Q3 us-gaap Royalty Revenue
RoyaltyRevenue
790000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-2094000
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1639000
CY2013Q3 us-gaap Revenues
Revenues
136874000
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-53020000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-53020000
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
574000
CY2013Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-3278000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
704000
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-101000
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-65000
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
1148000
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
28054000
CY2013Q3 us-gaap Depreciation
Depreciation
9200000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-5296000
CY2013Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
1732000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
187598000
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0
CY2013Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-4148000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
1184000
CY2013Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0
CY2013Q3 bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
9639000
CY2013Q3 bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
2800000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2014Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
2238000 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
642000 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
9275000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159304000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2014Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
133000 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12240000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147016000 shares
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7601000
CY2014Q3 us-gaap Contracts Revenue
ContractsRevenue
353000
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
173416000
CY2014Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
10330000
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9248000
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-3000
CY2014Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-74000
CY2014Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
4138000
CY2014Q3 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
14465000
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax
203000
CY2014Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2645000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
11203000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16693000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4138000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3221000
CY2014Q3 us-gaap Royalty Revenue
RoyaltyRevenue
3078000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
6247000
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3000
CY2014Q3 us-gaap Revenues
Revenues
176847000
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7445000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
7445000
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1435000
CY2014Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
156000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
9768000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2645000
CY2014Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
6606000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-225000
CY2014Q3 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
67500000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20004000
CY2014Q3 us-gaap Interest Expense
InterestExpense
9118000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
125686000
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74604000
CY2014Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-1493000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4224000
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-562000
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-359000
CY2014Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-3724000
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
29920000
CY2014Q3 us-gaap Depreciation
Depreciation
11200000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1493000
CY2014Q3 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
165644000
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0
CY2014Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-5217000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-3521000
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0
CY2014Q3 bmrn Intangible Asset Amortization And Contingent Consideration
IntangibleAssetAmortizationAndContingentConsideration
2934000
CY2014Q3 bmrn Depreciation Expense Capitalized Into Inventory
DepreciationExpenseCapitalizedIntoInventory
2600000

Files In Submission

Name View Source Status
0001193125-14-384895-index-headers.html Edgar Link pending
0001193125-14-384895-index.html Edgar Link pending
0001193125-14-384895.txt Edgar Link pending
0001193125-14-384895-xbrl.zip Edgar Link pending
bmrn-20140930.xml Edgar Link completed
bmrn-20140930.xsd Edgar Link pending
bmrn-20140930_cal.xml Edgar Link unprocessable
bmrn-20140930_def.xml Edgar Link unprocessable
bmrn-20140930_lab.xml Edgar Link unprocessable
bmrn-20140930_pre.xml Edgar Link unprocessable
d798950d10q.htm Edgar Link pending
d798950dex101.htm Edgar Link pending
d798950dex311.htm Edgar Link pending
d798950dex312.htm Edgar Link pending
d798950dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending